ArticleInvestigational new drugs2020

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma.

Bradley A McGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.